Provided by Tiger Trade Technology Pte. Ltd.

NovoCure

14.99
+3.2527.68%
Post-market: 14.97-0.0185-0.12%19:55 EST
Volume:8.26M
Turnover:121.18M
Market Cap:1.68B
PE:-9.33
High:15.46
Open:12.56
Low:12.50
Close:11.74
52wk High:22.30
52wk Low:9.82
Shares:111.98M
Float Shares:94.15M
Volume Ratio:5.13
T/O Rate:8.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6074
EPS(LYR):-1.5638
ROE:-50.60%
ROA:-8.30%
PB:4.92
PE(LYR):-9.59

Loading ...

Earning Preview: NovoCure Q4 revenue is expected to increase by 9.85%, and institutional views are balanced-to-cautious

Earnings Agent
·
Feb 19

NovoCure Up Over 27%, On Pace for Largest Percent Increase Since December 2024 -- Data Talk

Dow Jones
·
6 hours ago

Novocure jumps 11% after CMS reinstates Medicare billing privileges

TIPRANKS
·
Yesterday

Novocure Ltd - CMS Reinstates Medicare Billing Privileges Retroactively - SEC Filing

THOMSON REUTERS
·
Yesterday

Novocure Ltd - Company Expects No Revenue Impact From Ineligibility Period - SEC Filing

THOMSON REUTERS
·
Yesterday

Novocure Inc. regains Medicare billing privileges after CMS rescinds revocation

Reuters
·
Yesterday

Sector Update: Health Care Stocks Higher Thursday Afternoon

MT Newswires Live
·
Feb 13

NovoCure Up Over 26%, on Pace for Largest Percent Increase Since December 2024 -- Data Talk

Dow Jones
·
Feb 13

Wedbush Remains a Hold on NovoCure (NVCR)

TIPRANKS
·
Feb 12

Stock Track | NovoCure Soars 40.48% in Pre-Market on FDA Approval for Pancreatic Cancer Treatment Device

Stock Track
·
Feb 12

FDA: Approved Novocure's Optune Pax, a First-of-Its-Kind Device for Treatment of Adult Patients With Locally Advanced Pancreatic Cancer

THOMSON REUTERS
·
Feb 12

NovoCure (NVCR) Gets a Buy from Piper Sandler

TIPRANKS
·
Feb 12

Top Premarket Gainers

MT Newswires Live
·
Feb 12

Novocure Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 12

These Stocks Are Today's Movers: Cisco, AppLovin, Micron, Fastly, Equinix, Rollins, Novocure, and More -- Barrons.com

Dow Jones
·
Feb 12

Stocks to Watch Thursday: Cisco, McDonald's, AppLovin -- WSJ

Dow Jones
·
Feb 12

Stock Track | NovoCure Soars 26.67% in Pre-market on FDA Approval for Pancreatic Cancer Treatment

Stock Track
·
Feb 12

Novocure Gets FDA Approval for Pancreatic Cancer Treatment; Shares Soar

Dow Jones
·
Feb 12

NovoCure (NVCR) Stock Is Trending Overnight — Here's What You Should Know

Benzinga_recent_news
·
Feb 12

U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer

THOMSON REUTERS
·
Feb 12